Press release
Tuberous Sclerosis Alliance and Nobelpharma to Celebrate Rare Disease Day -Feb. 26, 2021 with New Partnership – Feb. 24, 2021
Contribute to Society by Providing Critical but Neglected Pharmaceuticals and Medical Devices.
Philosophy
We contribute to society by developing drugs and medical devices for diseases that large pharmaceutical companies overlook because of the small number of patients or for other reason, and to deliver these drugs and devices where they are needed.
History
We will continue to further evolve by developing First-In-Class & Best-In-Class drugs, aiming at a wide launch from Japan to the United States.
Message from President & CEO
Nobelpharma America, LLC is the first oversea subsidiary of Nobelpharma Co., Ltd. in Tokyo, Japan for the purpose of expanding our business to the United States.
Pipeline
Nobelpharma America, LLC has earnestly addressed the development of medicines that other companies do not pursue, in order to fulfill the needs of society. Read more>>
“Critical but neglected – That is precisely why it must be created.”
We, Nobelpharma, born in 2003 Tokyo Japan to fulfill the mission of “Contribute to medical care by developing, manufacturing and delivering essential medicines that other company do not pursue,” have obtained approvals for the manufacture and sales of new drugs in numbers on par with large pharmaceutical companies in a little more than 10 years, and we have been providing these drugs to patients. We take much pride in the corporate philosophy that is unique to Nobelpharma that made this possible.